CRBP · Corbus Pharmaceuticals Holdings, Inc. · Share Buybacks
$2.06
-0.38 (-15.40%)
At close · Nov 20
Return incl. dividend (before tax)
Q4 2020 earnings call transcript
Market Cap
$42.45M
Shares
20.61M
Volume · Nov 20
1.38M
Avg daily vol (3M)
1.1M
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Share-repurchase activity from the company's own XBRL filings — cash spent buying back common stock per fiscal year and per recent quarter, share counts where the company tagged them, and the buyback program's authorization — paired with the company's at-the-market (ATM) equity offering programs, the dilution side of the same picture. Repurchase amounts come exclusively from tagged SEC data; program figures with no tagged equivalent (untagged authorizations and all ATM figures) are read from the filing's own text and shown only after verification.
Equity Offering (ATM) Programs
| Program Established | Last Amended | Capacity | Remaining | Runs Through | Source |
|---|---|---|---|---|---|
| 2020-08-06 | 2023-05-31 | $150,000,000 | $69,100,000 as of 2026-03-31 | — | 10-Q , filed 2026-08-06 |
Key facts
CIK
1595097
CUSIP
21833P301
13F (30d)
129 filings
111 filers
Visit website
Investor relations